AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 52 filers reported holding AQUINOX PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $127,000 | -14.8% | 53,687 | -3.3% | 0.00% | – |
Q1 2019 | $149,000 | +24.2% | 55,543 | 0.0% | 0.00% | – |
Q4 2018 | $120,000 | -53.7% | 55,543 | -37.2% | 0.00% | – |
Q3 2018 | $259,000 | +10.2% | 88,437 | -0.1% | 0.00% | – |
Q2 2018 | $235,000 | -81.2% | 88,493 | -0.3% | 0.00% | – |
Q1 2018 | $1,250,000 | +25.3% | 88,770 | +4.7% | 0.00% | – |
Q4 2017 | $998,000 | -17.5% | 84,817 | -0.5% | 0.00% | – |
Q3 2017 | $1,209,000 | +3.2% | 85,239 | +2.4% | 0.00% | – |
Q2 2017 | $1,171,000 | -12.9% | 83,207 | +3.3% | 0.00% | – |
Q1 2017 | $1,344,000 | -0.9% | 80,516 | -2.0% | 0.00% | – |
Q4 2016 | $1,356,000 | +58.4% | 82,121 | +28.2% | 0.00% | – |
Q3 2016 | $856,000 | +154.8% | 64,033 | +26.2% | 0.00% | – |
Q2 2016 | $336,000 | +184.7% | 50,732 | +277.6% | 0.00% | – |
Q1 2016 | $118,000 | -29.8% | 13,434 | 0.0% | 0.00% | – |
Q4 2015 | $168,000 | -11.1% | 13,434 | 0.0% | 0.00% | – |
Q3 2015 | $189,000 | – | 13,434 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 877,753 | $14,492,000 | 5.61% |
RA Capital Management | 2,191,977 | $36,190,000 | 5.13% |
Opaleye Management Inc. | 310,000 | $5,118,000 | 3.02% |
EMORY UNIVERSITY | 143,691 | $2,372,000 | 2.34% |
Baker Brothers Advisors | 10,536,092 | $173,951,000 | 1.70% |
Ghost Tree Capital, LLC | 225,000 | $3,715,000 | 0.89% |
Cormorant Asset Management, LP | 151,838 | $2,507,000 | 0.34% |
Eventide Asset Management | 175,000 | $2,889,000 | 0.19% |
JGP Global Gestao de Recursos Ltda. | 11,380 | $188,000 | 0.10% |
Virtus ETF Advisers LLC | 16,347 | $270,000 | 0.08% |